BG00011

Biogen stops Phase 2 study in another hit to 'high-risk' pipeline
Biopharma Dive
Tue, 09/17/19 - 03:38 pm
Biogen
clinical trials
IPF
idiopathic pulmonary fibrosis
BG00011